Safety and Efficacy of RX-af01 Combined With PD-1 Antibody

NCT05576961 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumor
Immune Checkpoint Inhibitor
Intestinal Flora

Interventions

DRUG: RX-af01
DRUG: Mixed bacteria
DRUG: High dose RX-af01

Sponsor

Sun Yat-sen University